REC IT0003828271

Report

Delayed Borsa Italiana - 11:35 2022-06-24 am EDT
41.86	EUR		+7.64%

06/20	RECORDATI : Share buy-back program to service the stock option plans	PU
06/14	RECORDATI : Ultima presentazione del gruppo	PU
06/14	RECORDATI : Latest Company presentation	PU

Company

Business Summary

Recordati specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (75.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (24.3%).

Net sales are distributed geographically as follows: Italy (16.8%), Europe (59.7%), America (14%), Asia and Oceania (6.3%) and Africa (3.2%).

Number of employees : 4 303 people.

Sales per Business

	2020		2021		Delta
Specialty & Primary Care	1 129.43	78%	1 196.22	75.7%	+5.91%
Orphan Drugs	319.44	22%	383.85	24.3%	+20.16%
EUR in Million

Sales per region

	2020		2021		Delta
Europe	857.42	59.2%	942.89	59.7%	+9.97%
Italy	274.59	19%	265.36	16.8%	-3.36%
America	169.37	11.7%	221.76	14%	+30.94%
Australasia	95.10	6.6%	99.53	6.3%	+4.66%
Africa	52.39	3.6%	50.52	3.2%	-3.57%
EUR in Million

Managers

Name	Title	Age	Since
Robert Koremans	Chief Executive Officer	59	2021
Luigi La Corte	Group Chief Financial Officer	52	2019
Raffaele Sabia	Senior VP-Pharmaceutical Research & Development	-	-
Giovanni Minora	Head-Group Audit & Compliance	-	2007
Federica de Medici	Director-Investor Relations & Communications	49	2020
Cédric Ripert	Vice President-Pharmaceuticals International Sales	-	2017
Fritz Squindo	Head-Management Accounting Department	66	1992
Witold Urban	VP-Central & Eastern Europe Region	-	-
Gabriele Finzi	Vice President-Corporate Development & Licensing	-	2019
Roberto Teruzzi	Executive VP-Group Industrial Operations	-	2015

Members of the board

Name	Title	Age	Since
Andrea Recordati	Chairman	50	2021
Michaela Castelli	Lead Independent Non-Executive Director	51	2014
Joanna Susan Le Couilliard	Independent Non-Executive Director	57	-
Piergiorgio Peluso	Independent Non-Executive Director	54	2020
Elisa Corghi	Independent Director	49	-
Fritz Squindo	Head-Management Accounting Department	66	1992
Giampiero Mazza	Executive Director	53	2019
Cathrin Petty	Executive Director	49	-
Guido Guidi, Dr.	Vice Chairman	69	-
Giorgio de Palma	Director	47	2020

Equities

	Vote	Quantity	Free-Float		Company-owned shares		Total Float
Stock A	1	209,125,156	97,218,698	46.5%	3,537,802	1.7%	46.5%

Shareholders

Name	Equities	%
FIMEI Finanziaria Industriale Mobiliare ed Immobiliare SpA	108,368,721	51.8%
Mawer Investment Management Ltd.	10,588,200	5.06%
Fidelity Management & Research Co. LLC	6,290,484	3.01%
Recordati Industria Chimica e Farmaceutica S.p.A.	3,777,524	1.81%
The Vanguard Group, Inc.	2,633,407	1.26%
Welch Capital Partners LLC	2,485,272	1.19%
BlackRock Fund Advisors	2,343,666	1.12%
Norges Bank Investment Management	1,749,557	0.84%
State Street Global Advisors Ltd.	1,593,541	0.76%
William Blair Investment Management LLC	1,319,242	0.63%

Holdings

Name	Equities	%	Valuation
RECORDATI (REC)	3,777,524	1.81%	168,665,313 USD
PURETECH HEALTH PLC (PRTC)	9,544,140	3.31%	21,771,520 USD
ERYTECH PHARMA S.A. (ERYP)	431,034	1.39%	529,159 USD